Prime Medicine Inc (PRME)
6.935
-0.52
(-6.91%)
USD |
NASDAQ |
May 23, 16:00
6.935
0.00 (0.00%)
After-Hours: 20:00
Prime Medicine Price to Book Value: 3.415 for May 23, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 22, 2024 | 3.668 |
| May 21, 2024 | 3.954 |
| May 20, 2024 | 3.708 |
| May 17, 2024 | 3.486 |
| May 16, 2024 | 3.466 |
| May 15, 2024 | 3.329 |
| May 14, 2024 | 3.279 |
| May 13, 2024 | 3.161 |
| May 10, 2024 | 2.762 |
| May 09, 2024 | 2.816 |
| May 08, 2024 | 2.639 |
| May 07, 2024 | 2.743 |
| May 06, 2024 | 2.659 |
| May 03, 2024 | 2.752 |
| May 02, 2024 | 2.762 |
| May 01, 2024 | 2.595 |
| April 30, 2024 | 2.423 |
| April 29, 2024 | 2.393 |
| April 26, 2024 | 2.179 |
| April 25, 2024 | 2.117 |
| April 24, 2024 | 2.314 |
| April 23, 2024 | 2.364 |
| April 22, 2024 | 2.354 |
| April 19, 2024 | 2.221 |
| April 18, 2024 | 2.260 |
| Date | Value |
|---|---|
| April 17, 2024 | 2.427 |
| April 16, 2024 | 2.595 |
| April 15, 2024 | 2.678 |
| April 12, 2024 | 2.821 |
| April 11, 2024 | 2.861 |
| April 10, 2024 | 2.90 |
| April 09, 2024 | 3.043 |
| April 08, 2024 | 3.003 |
| April 05, 2024 | 2.831 |
| April 04, 2024 | 2.851 |
| April 03, 2024 | 2.856 |
| April 02, 2024 | 3.112 |
| April 01, 2024 | 3.328 |
| March 31, 2024 | |
| March 28, 2024 | 6.309 |
| March 27, 2024 | 6.093 |
| March 26, 2024 | 6.003 |
| March 25, 2024 | 6.192 |
| March 22, 2024 | 6.246 |
| March 21, 2024 | 6.616 |
| March 20, 2024 | 6.643 |
| March 19, 2024 | 6.408 |
| March 18, 2024 | 6.327 |
| March 15, 2024 | 6.453 |
| March 14, 2024 | 6.206 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.117
Minimum
Apr 25 2024
8.463
Maximum
Feb 27 2024
4.788
Average
4.837
Median
Jan 23 2024
Price to Book Value Benchmarks
| Pacific Biosciences of California Inc | 0.8183 |
| 10x Genomics Inc | 3.822 |
| Recursion Pharmaceuticals Inc | 5.356 |
| Verve Therapeutics Inc | 0.7682 |
| Ginkgo Bioworks Holdings Inc | 1.476 |
Price to Book Value Related Metrics
| Price | 6.935 |
| Earnings Yield | -31.43% |
| Market Cap | 832.41M |